Initial Exploration of the BET Inhibitor RO6870810 in the Treatment of Solid Tumors and Lymphomas

LUO Qiang; MENG Rui

doi:10.12019/j.issn.1671-5144.202410035

LUO Qiang, MENG Rui. Initial Exploration of the BET Inhibitor RO6870810 in the Treatment of Solid Tumors and Lymphomas[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 284-289, 320. DOI: 10.12019/j.issn.1671-5144.202410035

Citation:

LUO Qiang, MENG Rui. Initial Exploration of the BET Inhibitor RO6870810 in the Treatment of Solid Tumors and Lymphomas[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 284-289, 320. DOI: 10.12019/j.issn.1671-5144.202410035

Citation:

LUO Qiang, MENG Rui. Initial Exploration of the BET Inhibitor RO6870810 in the Treatment of Solid Tumors and Lymphomas[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 284-289, 320. DOI: 10.12019/j.issn.1671-5144.202410035

Initial Exploration of the BET Inhibitor RO6870810 in the Treatment of Solid Tumors and Lymphomas

LUO Qiang,
MENG Rui

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (22)

Initial Exploration of the BET Inhibitor RO6870810 in the Treatment of Solid Tumors and Lymphomas

Graphical Abstract

Catalog

Export File

Citation

Format

Content